1. Home
  2. APLS vs VICR Comparison

APLS vs VICR Comparison

Compare APLS & VICR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • VICR
  • Stock Information
  • Founded
  • APLS 2009
  • VICR 1981
  • Country
  • APLS United States
  • VICR United States
  • Employees
  • APLS N/A
  • VICR N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • VICR Industrial Machinery/Components
  • Sector
  • APLS Health Care
  • VICR Technology
  • Exchange
  • APLS Nasdaq
  • VICR Nasdaq
  • Market Cap
  • APLS 2.2B
  • VICR 1.9B
  • IPO Year
  • APLS 2017
  • VICR N/A
  • Fundamental
  • Price
  • APLS $18.90
  • VICR $45.63
  • Analyst Decision
  • APLS Buy
  • VICR Hold
  • Analyst Count
  • APLS 19
  • VICR 2
  • Target Price
  • APLS $37.61
  • VICR $43.00
  • AVG Volume (30 Days)
  • APLS 2.1M
  • VICR 392.3K
  • Earning Date
  • APLS 07-31-2025
  • VICR 07-22-2025
  • Dividend Yield
  • APLS N/A
  • VICR N/A
  • EPS Growth
  • APLS N/A
  • VICR 576.06
  • EPS
  • APLS N/A
  • VICR 1.45
  • Revenue
  • APLS $775,839,000.00
  • VICR $379,346,000.00
  • Revenue This Year
  • APLS $8.00
  • VICR $14.66
  • Revenue Next Year
  • APLS $13.82
  • VICR $15.24
  • P/E Ratio
  • APLS N/A
  • VICR $31.71
  • Revenue Growth
  • APLS 48.04
  • VICR 2.46
  • 52 Week Low
  • APLS $16.10
  • VICR $34.27
  • 52 Week High
  • APLS $41.94
  • VICR $65.70
  • Technical
  • Relative Strength Index (RSI)
  • APLS 51.99
  • VICR 48.23
  • Support Level
  • APLS $19.16
  • VICR $45.06
  • Resistance Level
  • APLS $20.40
  • VICR $63.00
  • Average True Range (ATR)
  • APLS 0.93
  • VICR 2.72
  • MACD
  • APLS -0.04
  • VICR -0.21
  • Stochastic Oscillator
  • APLS 32.64
  • VICR 11.26

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About VICR Vicor Corporation

Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others.

Share on Social Networks: